Related Experiment Video
Updated: May 5, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
XPC promotes MDM2-mediated degradation of the p53 tumor suppressor
Jing Yan Krzeszinski1, Vitnary Choe, Jia Shao
1State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200433, People's Republic of China Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 First Affiliated Hospital, Nanchang University, Jiangxi 330006, People's Republic of China.
Abstract:
Although ubiquitin receptor Rad23 has been implicated in bringing ubiquitylated p53 to the proteasome, how Rad23 recognizes p53 remains unclear. We demonstrate that XPC, a Rad23-binding protein, regulates p53 turnover. p53 protein in XPC-deficient cells remains ubiquitylated, but its association with the proteasome is drastically reduced, indicating that XPC regulates a postubiquitylation event. Furthermore, we found that XPC participates in the MDM2-mediated p53 degradation pathway via direct interaction with MDM2. XPC W690S pathogenic mutant is specifically defective for MDM2 binding and p53 degradation. p53 is known to become stabilized following UV irradiation but can be rendered unstable by XPC overexpression, underscoring a critical role of XPC in p53 regulation. Elucidation of the proteolytic role of XPC in cancer cells will help to unravel the detailed mechanisms underlying the coordination of DNA repair and proteolysis.
Insights
The DNA repair protein XPC regulates the degradation of the tumor suppressor p53 by directly interacting with MDM2. This interaction is crucial for targeting ubiquitylated p53 to the proteasome for destruction.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The ubiquitin receptor Rad23 facilitates p53 proteasomal degradation, but its recognition mechanism for p53 is unknown.
- Understanding p53 turnover is critical for cancer biology, as p53 is a key tumor suppressor.
Purpose of the Study:
- To elucidate the role of XPC, a Rad23-binding protein, in the regulation of p53 protein stability and degradation.
- To investigate the mechanism by which XPC influences p53 turnover and its interaction with the proteasome.
Main Methods:
- Assessing p53 ubiquitylation and proteasomal association in XPC-deficient cells.
- Investigating the direct interaction between XPC and MDM2.
- Analyzing the impact of a pathogenic XPC mutant (W690S) on p53 degradation.
Main Results:
- XPC deficiency leads to ubiquitylated p53 with reduced proteasomal association, indicating a post-ubiquitylation regulatory role for XPC.
- XPC directly interacts with MDM2, participating in the MDM2-mediated p53 degradation pathway.
- The XPC W690S mutant shows impaired MDM2 binding and p53 degradation.
- XPC overexpression destabilizes p53, while UV irradiation stabilizes it, highlighting XPC's critical regulatory function.
Conclusions:
- XPC plays a crucial role in regulating p53 protein degradation through its interaction with MDM2.
- This finding reveals a novel link between DNA repair (XPC) and proteolysis (p53 degradation), impacting cancer cell mechanisms.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity

